Hello, Fool! | Login | Signup | My Fool
Oct 13, 2008 4:31 PM ET | Feedback | Site Changes | Help
A biotechnology company focused on the development and commercialization of novel biological therapies for patients with cancer.
View All Commentary (CEGE)
Recs
2tal (61.48) Submitted: 4/10/07 1:52 PM : Start Price: $6.25 CEGE Score: -59.08
Another small biotech I jumped in and watched it fall but now it is starting to run. Their work is paying off and the stock price will reflect that. Maybe it is time to buy my second third?!
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK